Clinical Trial Update: A Study in Subjects With Retinal Detachment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating an investigational agent for retinal detachment; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Detachment

Drugs mentioned

• Investigational agent (name not disclosed)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Retinal Detachment | Phase 1 | Status: COMPLETED